Posts Tagged ‘clinical trials’
A pilot study reveals blocking the IL-17 pathway is safe and feasible for primary sclerosing cholangitis
A pilot study reveals blocking the IL-17 pathway is safe and feasible for primary sclerosing cholangitis.
Read MoreVolixibat Announcement at EASL Congress 2026
The latest results from the VISTAS trial to reduce itch in PSC.
Read MoreUpcoming Ask the Expert Live | PSC Research Round-up: Latest Updates from EASL
Register for our upcoming Ask the Expert live PSC Q&A with Dr Trivedi, taking place on 25th June at 7pm (UK).
Read MoreVISTAS Phase 2b Trial Results May 2026
New trial data shows volixibat significantly reduces severe itch for people with PSC.
Read MoreSABR-PSC Clinical Trial Results
Early-phase study shows brodalumab is safe and well-tolerated in people with PSC.
Read MoreRitivixibat (A3907) Phase 2 Clinical Trial Results
Safety results for the Phase 2 ritivixibat study (A3907) for PSC have been released.
Read MoreUpcoming Ask the Expert Webinar – The Asp-PSC Trial: What Patients Need to Know
Register for our first live Ask the Expert of 2026, taking place on Monday 2nd March at 7pm (UK).
Read MorePSC Treatment Breakthroughs 2025
Discover the 2025 breakthroughs in PSC research and how they are shaping 2026.
Read MoreELMWOOD Clinical Trial Update
Latest results shared at international liver conference.
Read MoreSPRING Clinical Trial Update
Latest results shared at international liver conference.
Read More